Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. März 2010 14:27 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Inc. Chosen on StockProfile.com

COLORADO SPRINGS, Colo., March 26, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce...
24. März 2010 14:17 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Demonstrates That Pharmaceutical Cannabis and Medical Marijuana Are Essential to Contain Health Care Costs and Give Patients Access to Affordable and Effective Medicines Offering the Obama Administration Non-Smoked Medical Marijuana Delivery Systems

COLORADO SPRINGS, Colo., March 24, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, calls pharmaceutical...
10. März 2010 12:30 ET | Quelle: Cannabis Science, Inc.

President Obama's Deputy Drug Czar Tom McClellan Comments in USA TODAY Article; Endorses Non-Smoked Medical Marijuana Delivery Systems Identical to the First Product Cannabis Science is Developing for FDA Clinical Trials for PTSD Targeting Our Veterans, Active Duty Troops, and Others Suffering from Disasters World-Wide

COLORADO SPRINGS, Colo., March 10, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering US pharmaceutical cannabis company, notes that comments by President Obama's Deputy...
08. März 2010 09:15 ET | Quelle: Cannabis Science, Inc.

Highly Specialized International FDA Regulatory Compliance Firm Signs With Cannabis Science to Prepare for Company's First Pre-Investigative New Drug (IND) Submission Package for Veterans PTSD Project

COLORADO SPRINGS, Colo., March 8, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering pharmaceutical cannabis company, is pleased to announce that it has formalized its...
04. März 2010 13:45 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Sets Second FDA Drug Target on $20 Billion "Chronic Pain" Market Targeting the Huge Need for Safe Non-Addictive Non-Lethal Cannabis Based Medications

COLORADO SPRINGS, Colo., March 4, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pharmaceutical cannabis company in the U.S., announced today that it has set its second...
02. März 2010 12:38 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Officially Begins Its First Pre-IND FDA Application Process for Post Traumatic Stress Disorder (PTSD)

COLORADO SPRINGS, Colo., March 2, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pharmaceutical cannabis company in the US, is pleased to announce that it now has the results of its...

Vorherige Seite